Gdansk, Poland

Barbara Horowska



 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Gdansk-Wrzeszcz, PL (1979)
  • Gdansk, PL (2019)

Company Filing History:


Years Active: 1979-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Barbara Horowska: Innovator in Antitumor Compounds

Introduction

Barbara Horowska is a prominent inventor based in Gdansk, Poland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor activity. With a total of 2 patents, her work has the potential to impact cancer treatment and prevention.

Latest Patents

Horowska's latest patents include "Asymmetric bis-acridines with antitumour activity and their uses." This patent discloses novel asymmetric bis-acridines that exhibit antitumor properties, making them valuable for pharmaceutical applications in treating or preventing neoplasms. Another significant patent is for "1-Nitro-9-alkylaminoalkylaminoacridines and salts thereof." This patent describes 1-nitro-9-alkylaminoalkylaminoacridines and their salts, along with a method for obtaining these compounds. These compounds are noted for their anti-neoplastic activity.

Career Highlights

Throughout her career, Barbara Horowska has worked with esteemed institutions such as Gdansk University of Technology. Her research and innovations have positioned her as a key figure in the development of new pharmaceutical compounds.

Collaborations

Horowska has collaborated with notable colleagues, including Andrzej Ledochowski and Jerzy Gieldanowski. Their joint efforts have contributed to advancing research in the field of antitumor compounds.

Conclusion

Barbara Horowska's innovative work in developing antitumor compounds showcases her dedication to improving cancer treatment options. Her patents reflect her significant contributions to the pharmaceutical industry, and her collaborations further enhance the impact of her research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…